FDA OK's Invitrogen genetic test for breast cancer
Tuesday, July 8, 2008 - 08:28
in Health & Medicine
WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Tuesday it approved Invitrogen Corp's genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin.